Breaking News Instant updates and real-time market news.

2020-11-24 07:00:34 07:00 11/24/20 11/24 07:00 11/24/20 07:00	INSU Acquisition Corporation II (Units) trading halted, news dissemination

TODAY'S FREE FLY STORIES

Downgrade	Gruma downgraded to Equal Weight from Overweight at Barclays » 06:34 01/19/21 01/19 06:34 01/19/21 06:34 GPAGF Gruma $34.00 / +14 (+5.00%) Barclays analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GPAGF Gruma $34.00 / +14 (+5.00%) 10/21/20 Morgan Stanley Gruma downgraded to Equal Weight from Overweight at Morgan Stanley 09/17/20 Citi Gruma downgraded to Neutral from Buy at Citi 07/13/20 Barclays Gruma upgraded to Overweight from Equal Weight at Barclays 01/21/20 Goldman Sachs Gruma upgraded to Buy from Neutral at Goldman Sachs
Syndicate	Senseonics raises $50M in a registered direct offering » 06:34 01/19/21 01/19 06:34 01/19/21 06:34 SENS Senseonics $1.57 / +0.375 (+31.38%) Senseonics announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SENS Senseonics $1.57 / +0.375 (+31.38%) 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA 08/10/20 Senseonics to partner with Ascensia Diabetes Care 08/07/20 Senseonics announces Highmark coverage for Eversense CGM to begin in September 07/29/20 Independence BCBS adds coverage for Senseonics' Eversense SENS Senseonics $1.57 / +0.375 (+31.38%) 12/24/20 BTIG Senseonics approval delay 'disappointing but understandable,' says BTIG 08/11/20 Craig-Hallum Senseonics upgraded to Hold at Craig-Hallum following Ascensia partnership 08/11/20 Craig-Hallum Senseonics upgraded to Hold from Sell at Craig-Hallum 08/11/20 BTIG Senseonics upgraded to Buy from Neutral at BTIG SENS Senseonics $1.57 / +0.375 (+31.38%) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 11/09/20 Senseonics reports Q3 EPS (10c), consensus (6c) 08/10/20 Senseonics reports Q2 EPS (3c), consensus (9c) SENS Senseonics $1.57 / +0.375 (+31.38%) 12/24/20 Fly Intel: Pre-market Movers SENS Senseonics $1.57 / +0.375 (+31.38%) 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th
Downgrade	Discovery downgraded to Underweight from Equal Weight at Barclays » 06:33 01/19/21 01/19 06:33 01/19/21 06:33 DISCA Discovery $36.76 / -0.49 (-1.32%) Barclays analyst Kannan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DISCA Discovery $36.76 / -0.49 (-1.32%) 01/04/21 Discovery CEO says 'not late, just in time' with streaming service launch 01/04/21 Discovery, Vodafone sign new long-term, multi-platform agreement 01/04/21 Discovery launches discovery+ in the U.S. 01/04/21 Discovery, Vodafone announce multi-platform agreement in Europe DISCA Discovery $36.76 / -0.49 (-1.32%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 MoffettNathanson Discovery upgraded to Buy with $45 price target at MoffettNathanson 01/15/21 MoffettNathanson Discovery upgraded to Buy from Neutral at MoffettNathanson 01/13/21 RBC Capital Discovery price target raised to $40 from $35 at RBC Capital DISCA Discovery $36.76 / -0.49 (-1.32%) 11/05/20 Discovery reports Q3 adjusted EPS 81c, consensus 65c 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 08/05/20 Discovery reports Q2 adjusted EPS 77c, consensus 70c DISCA Discovery $36.76 / -0.49 (-1.32%) 12/23/20 Discovery raises stake in OWN JV with Oprah to 95%, Variety reports 12/02/20 Discovery to launch streaming service in January for $4.99 per month, CNBC says 12/02/20 Discovery partnering with Verizon on Discovery+ launch, CNBC says 08/24/20 Old media 'giants' cashing in on streaming, especially Disney, Bloomberg says DISCA Discovery $36.76 / -0.49 (-1.32%) 12/09/20 Disney upgrade, Zoom Video downgrade among today's top calls on Wall Street 11/05/20 Fly Intel: Pre-market Movers DISCA Discovery $36.76 / -0.49 (-1.32%) 09/17/20 Early notable gainers among liquid option names on September 17th
Hot Stocks	Matrix Service subsidiary awarded construction of water facility by Corteva » 06:33 01/19/21 01/19 06:33 01/19/21 06:33 MTRX Matrix Service $13.85 / -1.03 (-6.92%) , CTVA Corteva $43.74 / -0.445 (-1.01%) Matrix Service Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CTVA CTVA Corteva $43.74 / -0.445 (-1.01%) 01/04/21 Corteva welcomes new Chief Technology Officer Sam Eathington 12/23/20 Tyson Foods appoints Megan Britt as VP, investor relations 11/13/20 Starboard Value takes Corteva stake, exits eBay 11/04/20 Corteva backs FY20 operating EBITDA view $1.9B-$2B MTRX CTVA MTRX Matrix Service $13.85 / -1.03 (-6.92%) 02/24/20 Jefferies Epizyme, Blueprint among cancer companies that fit M&A criteria, says Jefferies 02/19/20 Fly Intel: Top five analyst upgrades 02/19/20 Sidoti Matrix Service upgraded to Buy following 28% pullback at Sidoti 02/19/20 Sidoti Matrix Service upgraded to Buy from Neutral at Sidoti CTVA Corteva $43.74 / -0.445 (-1.01%) 01/08/21 Deutsche Bank Corteva price target raised to $50 from $40 at Deutsche Bank 12/18/20 Susquehanna Corteva downgraded to Neutral from Positive at Susquehanna 12/14/20 Morgan Stanley Morgan Stanley upgrades Corteva, points to five reasons for above-consensus view 12/14/20 Morgan Stanley Corteva upgraded to Overweight from Equal Weight at Morgan Stanley MTRX CTVA MTRX Matrix Service $13.85 / -1.03 (-6.92%) 01/12/21 Chart Industries, Matrix Service sign commercial hydrogen MOU 11/04/20 Matrix Service reports Q1 EPS (12c), consensus 3c CTVA Corteva $43.74 / -0.445 (-1.01%) 11/04/20 Corteva backs FY20 operating EPS view $1.25-$1.45, consensus $1.38 11/04/20 Corteva reports Q3 adjusted EPS (39c), consensus (42c) 11/04/20 Notable companies reporting after market close 08/05/20 Corteva sees FY20 operating EPS $1.25-$1.45, consensus $1.40 CTVA CTVA Corteva $43.74 / -0.445 (-1.01%) 11/19/20 Corteva board backs CEO amid pressure from Starboard, Reuters says 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports 02/04/21 Corteva - CTVA
Earnings	Gannett sees Q4 revenue $865M-$875M, consensus $869.95M » 06:33 01/19/21 01/19 06:33 01/19/21 06:33 GCI Gannett $3.98 / -0.005 (-0.13%) Sees Q4 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events GCI Gannett $3.98 / -0.005 (-0.13%) 01/12/21 Gannett rises 20.3% 12/29/20 Gannett rises 11.6% 12/22/20 Gannett terminates its external management agreement with FIG 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan GCI Gannett $3.98 / -0.005 (-0.13%) 04/05/20 Citi Gannett downgraded to Sell from Buy at Citi 03/17/20 Citi Gannett price target lowered to $5 from $9 at Citi GCI Gannett $3.98 / -0.005 (-0.13%) 11/03/20 Gannett reports Q3 EPS (24c), consensus (44c) 08/06/20 Gannett reports Q2 EPS ($3.32), consensus (62c) GCI Gannett $3.98 / -0.005 (-0.13%) 11/13/20 Gannett to see 500 employees take voluntary buyouts, NY Post reports 02/26/21 Gannett Co Inc.

Downgrade	Femsa downgraded to Equal Weight from Overweight at Barclays » 06:33 01/19/21 01/19 06:33 01/19/21 06:33 FMX Femsa $75.75 / -1.06 (-1.38%) Barclays analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FMX Femsa $75.75 / -1.06 (-1.38%) 12/16/20 Femsa buys Southeastern Paper Group and Southwest Paper Company 10/08/20 Femsa reaches deal with SMU to acquire OK Market stores for CLP43.5B FMX Femsa $75.75 / -1.06 (-1.38%) 12/03/20 Morgan Stanley Femsa downgraded to Equal Weight from Overweight at Morgan Stanley 11/30/20 Itau BBA Femsa downgraded to Market Perform from Outperform at Itau BBA 05/04/20 BofA Femsa downgraded to Underperform from Neutral at BofA FMX Femsa $75.75 / -1.06 (-1.38%) 07/24/20 Femsa reports Q1 revenue dow 10.7%
Downgrade	Virgin Galactic downgraded to Neutral from Positive at Susquehanna » 06:32 01/19/21 01/19 06:32 01/19/21 06:32 SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) Susquehanna analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 01/14/21 Virgin Galactic rises 15.2% 12/16/20 Virgin Galactic rises 9.5% 12/14/20 Virgin Galactic falls -15.4% 12/14/20 Virgin Galactic falls -13.0% SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 10/23/20 Fly Intel: Pre-market Movers 10/23/20 Goldman Sachs Virgin Galactic initiated with a Neutral at Goldman Sachs 09/28/20 Fly Intel: Top five analyst initiations 09/28/20 Susquehanna Susquehanna starts Virgin Galactic with Positive rating, $20 price target SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 11/05/20 Virgin Galactic reports Q3 EPS (34c), consensus (26c) 08/03/20 Virgin Galactic reports Q2 EPS (30c), consensus (26c) 06 Aug 03 Jun 20 May SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 10/20/20 Chanos 'joking' when talking 'positively' about space companies, CNBC says 07/23/20 SpaceX in talks to raise about $1B at $44B valuation, Bloomberg says SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 12/14/20 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Pre-market Movers 09/28/20 Virgin Galactic rockets higher as analysts tout 'unparalleled' growth potential 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns 02/25/21 Virgin Galactic - SPCE SPCE Virgin Galactic $30.52 / -2.445 (-7.42%) 01/14/21 Virgin Galactic call volume above normal and directionally bullish 01/12/21 Virgin Galactic call volume above normal and directionally bullish 12/24/20 Largest borrow rate increases among liquid names 12/22/20 Virgin Galactic call volume above normal and directionally bullish
Hot Stocks	Total to acquire 20% interest in Adani Green Energy from Adani Group » 06:32 01/19/21 01/19 06:32 01/19/21 06:32 TOT Total $37.00 / +19 (+4.00%) Total announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals TOT Total $37.00 / +19 (+4.00%) 01/15/21 Total opts not to renew API membership for 2021 01/14/21 Apache announces fourth oil discovery at Keskesi East-1 Well 12/21/20 Clean Energy, Total announce MOU to create 50/50 RNG joint venture 12/10/20 S&P Global WIM used for first LNG futures trade between Glencore, Total TOT Total $37.00 / +19 (+4.00%) 01/15/21 JPMorgan Total price target raised to EUR 46 from EUR 44 at JPMorgan 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/13/21 Credit Suisse Total price target raised to EUR 41.50 from EUR 39 at Credit Suisse 01/11/21 Mizuho Total initiated with a Neutral at Mizuho TOT Total $37.00 / +19 (+4.00%) 01/05/21 Saudi Arabia, Russia reach oil compromise, WSJ reports 01/05/21 OPEC+ reaches deal to hold oil output broadly steady, Bloomberg says 12/03/20 OPEC, allies agree to output boost of 500,000 barrels a day,WSJ reports 12/03/20 OPEC+ agrees on modest oil output increase from January, Reuters says
Downgrade	ViacomCBS downgraded to Underweight from Overweight at Barclays » 06:30 01/19/21 01/19 06:30 01/19/21 06:30 VIAC ViacomCBS $45.29 / -0.71 (-1.54%) Barclays analyst Kannan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 01/15/21 AMC Networks appoints Christina Spade as CFO 01/14/21 ViacomCBS delivers 1st time broadcast inventory enabled via MVPD set-top box 01/14/21 iQIYI announces 'Deer Squad' to premiere in the U.S. this month 01/04/21 ViacomCBS announces new, expanded distribution agreement with Hulu VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 01/15/21 MoffettNathanson ViacomCBS price target raised to $50 from $26 at MoffettNathanson 01/12/21 Wells Fargo ViacomCBS price target raised to $43 from $30 at Wells Fargo 01/05/21 Gabelli ViacomCBS named a best idea for 2021 at Gabelli 01/05/21 Goldman Sachs ViacomCBS price target raised to $40 from $37 at Goldman Sachs VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 11/06/20 ViacomCBS reports Q3 adj. EPS 91c, consensus 80c 11/05/20 Notable companies reporting before tomorrow's open 11/05/20 Notable companies reporting before tomorrow's open 08/06/20 ViacomCBS reports Q2 EPS $1.25, consensus 93c VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 12/10/20 Disney, NBCUniversal unlikely to follow WarnerMedia's 2021 media plan, CNBC says 11/24/20 Bertelsmann in lead to buy Simon & Schuster from ViacomCBS, FT reports 11/17/20 News Corp. to bid for ViacomCBS publisher Simon & Schuster, FT reports VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 12/09/20 Disney upgrade, Zoom Video downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Pre-market Movers 08/06/20 Fly Intel: Pre-market Movers VIAC ViacomCBS $45.29 / -0.71 (-1.54%) 12/14/20 ViacomCBS Class B put volume heavy and directionally bearish 12/11/20 ViacomCBS Class B call volume above normal and directionally bullish 11/23/20 ViacomCBS Class B call volume above normal and directionally bullish 11/20/20 ViacomCBS Class B call volume above normal and directionally bullish
Periodicals	TSMC, UMC to see full capacity utilization for 28nm through Q3, DigiTimes says » 06:29 01/19/21 01/19 06:29 01/19/21 06:29 TSM TSMC $125.26 / -1.04 (-0.82%) , UMC UMC $8.79 / -0.715 (-7.52%) Both TSMC (TSM) and UMC… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSM UMC TSM TSMC $125.26 / -1.04 (-0.82%) 01/14/21 TSMC sees FY21 CapEx $25B-$28B 01/08/21 TSMC reports December revenue NT$117.37B, up 13.6% y/y 11/10/20 TSMC reports October revenue NT$119.3B, up 12.5% y/y 10/08/20 TSMC reports September revenue NT$127.59B, up 24.9% y/y UMC UMC $8.79 / -0.715 (-7.52%) 12/08/20 UMC reports November sales of NT$14.73M, up 6% 12/04/20 UMC rises 12.2% 12/04/20 UMC rises 10.6% 11/23/20 UMC rises 16.4% TSM UMC TSM TSMC $125.26 / -1.04 (-0.82%) 01/14/21 Needham Intel upgraded to Buy from Hold at Needham 01/12/21 Fly Intel: Top five analyst upgrades 01/12/21 Bernstein TSMC upgraded to Outperform from Market Perform at Bernstein 12/29/20 RBC Capital Intel intraday move on Third Point news looks 'overdone,' says RBC Capital UMC UMC $8.79 / -0.715 (-7.52%) 10/12/20 Credit Suisse UMC upgraded to Outperform from Neutral at Credit Suisse 09/14/20 HSBC UMC upgraded to Buy from Hold at HSBC 09/09/20 JPMorgan UMC upgraded to Neutral from Underweight at JPMorgan 08/02/20 Goldman Sachs UMC upgraded to Buy from Neutral at Goldman Sachs TSM TSM TSMC $125.26 / -1.04 (-0.82%) 01/14/21 TSMC sees Q1 revenue $12.7B-$13B, consensus $12.62B 01/14/21 TSMC reports Q4 EPS 97c, consensus 94c 10/15/20 TSMC sees Q4 revenue $12.4B-$12.7B, consensus $11.71B 10/15/20 TSMC reports Q3 EPS 90c, consensus 77c TSM TSM TSMC $125.26 / -1.04 (-0.82%) 01/14/21 TSMC pledges to fix global auto chip shortage, FT reports 01/12/21 Intel plans to outsource production of new chips to TSMC, Reuters reports 01/08/21 Intel has talked with TSMC, Samsung about outsourcing chips, Bloomberg reports 01/08/21 Intel has talked with TSMC, Samsung about outsourcing chips, Bloomberg reports TSM TSM TSMC $125.26 / -1.04 (-0.82%) 01/14/21 AMD slips as analyst says sell on Gelsinger's return to Intel 01/14/21 Fly Intel: Pre-market Movers 01/27/21 UMC - UMC TSM UMC TSM TSMC $125.26 / -1.04 (-0.82%) 12/15/20 Taiwan Semi call volume above normal and directionally bullish 12/11/20 Unusual call flow in option market yesterday 12/10/20 Call sale in Taiwan Semiconductor exits short-term trade for $3.2M loss 12/04/20 Taiwan Semi call volume above normal and directionally bullish UMC UMC $8.79 / -0.715 (-7.52%) 12/24/20 United Microelectronics call volume above normal and directionally bullish

Syndicate	ProPhase Labs 3M share Secondary priced at $12.50 » 06:28 01/19/21 01/19 06:28 01/19/21 06:28 PRPH ProPhase Labs $15.80 / +0.35 (+2.27%) ThinkEquity, a division… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events PRPH ProPhase Labs $15.80 / +0.35 (+2.27%) 12/08/20 ProPhase Labs expands COVID testing capacity with location in Garden City ,NY 11/02/20 ProPhase Labs completes acquisition of CLIA accredited lab 10/23/20 ProPhase Labs to acquire CLIA accredited laboratory for $2.5M 09/30/20 ProPhase to explore CLIA lab acquisition, enters agreement with Predictive Labs PRPH ProPhase Labs $15.80 / +0.35 (+2.27%) 08/11/20 ProPhase Labs reports Q2 EPS 1c vs. (11c) last year 00:00 Today 17th Annual Small & Microcap Virtual Investor Conference
Syndicate	TCR2 Therapeutics files to sell $125M in common stock » 06:27 01/19/21 01/19 06:27 01/19/21 06:27 TCRR TCR2 Therapeutics $32.87 / -0.93 (-2.75%) Goldman Sachs & Co.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate TCRR TCR2 Therapeutics $32.87 / -0.93 (-2.75%) 01/08/21 TCR2 Therapeutics announces 2021 strategic priorities, milestones 12/13/20 TCR2 announces interim data from ongoing Phase 1 of TC-210 Phase 1/2 trial 12/11/20 TCR2 Therapeutics to announce TC-210 interim data 11/10/20 TCR2 Therapeutics partners with ElevateBio to expand TC-210 capacity TCRR TCR2 Therapeutics $32.87 / -0.93 (-2.75%) 12/22/20 Mizuho Autolus, Arcus among top 2021 oncology picks at Mizuho 12/15/20 Mizuho TCR2 Therapeutics price target raised to $58 from $33 at Mizuho 12/14/20 Piper Sandler TCR2 Therapeutics price target raised to $45 from $35 at Piper Sandler 12/14/20 BMO Capital TCR2 Therapeutics price target raised to $65 from $46 at BMO Capital TCRR TCR2 Therapeutics $32.87 / -0.93 (-2.75%) 11/12/20 TCR2 Therapeutics reports Q3 EPS (56c), consensus (53c) 08/12/20 TCR2 Therapeutics reports Q2 EPS (67c), consensus (64c) 29 Jul
Downgrade	Acadia Realty Trust downgraded to Neutral from Buy at BofA » 06:27 01/19/21 01/19 06:27 01/19/21 06:27 AKR Acadia Realty Trust $15.69 / -0.07 (-0.44%) BofA analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings AKR Acadia Realty Trust $15.69 / -0.07 (-0.44%) 06:10 Today BofA Acadia Realty Trust downgraded to Neutral from Buy at BofA 01/13/21 Jefferies Jefferies upgrades 'overlooked' Acadia Realty Trust to Buy 01/13/21 Jefferies Acadia Realty Trust upgraded to Buy from Hold at Jefferies 12/30/20 Truist Acadia Realty Trust price target raised to $15 from $12 at Truist AKR Acadia Realty Trust $15.69 / -0.07 (-0.44%) 11/03/20 Acadia Realty Trust reports Q3 FFO ex-items 20c, consensus 23c 08/05/20 Acadia Realty Trust reports Q2 adjusted FFO 29c, consensus 31c
Upgrade	Alsea upgraded to Overweight from Equal Weight at Barclays » 06:27 01/19/21 01/19 06:27 01/19/21 06:27 ALSSF Alsea $0.00 / + (+0.00%) Barclays analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Street Research ALSSF Alsea $0.00 / + (+0.00%) 11/02/20 Scotiabank Alsea downgraded to Sector Perform from Outperform at Scotiabank 09/09/20 BBVA Alsea upgraded to Outperform from Underperform at BBVA 06/26/20 Morgan Stanley Alsea upgraded to Overweight from Equal Weight at Morgan Stanley
Periodicals	Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports » 06:25 01/19/21 01/19 06:25 01/19/21 06:25 TSLA Tesla $826.55 / -17.94 (-2.12%) Tesla on Friday filed a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $826.55 / -17.94 (-2.12%) 01/14/21 Tesla director sells 10K shares of common stock 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Tesla Model Y achieves 5-Star overall safety rating from NHTSA 01/11/21 Tesla's Andy Hamilton leaves car maker to join Redwood Materials TSLA Tesla $826.55 / -17.94 (-2.12%) 01/15/21 Wedbush Tesla price target raised to $950 from $715 at Wedbush 01/13/21 Fly Intel: Top five analyst initiations 01/13/21 Edward Jones Edward Jones starts Tesla at Hold, sees leadership balanced by competition 01/13/21 Edward Jones Tesla initiated with a Hold at Edward Jones TSLA Tesla $826.55 / -17.94 (-2.12%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close 14 Feb TSLA Tesla $826.55 / -17.94 (-2.12%) 01/18/21 Tesla says Model Y deliveries in China have officially begun 01/13/21 NHTSA asks Tesla to recall 158,000 cars over faulty touchscreens, Reuters says 01/10/21 Tesla hunts for design chief to create vehicles for China, Reuters reports 01/07/21 Apple self-driving EV at least half a decade away, Bloomberg reports TSLA Tesla $826.55 / -17.94 (-2.12%) 01/14/21 Fly Intel: Pre-market Movers 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla 01/08/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers 01/27/21 Tesla - TSLA TSLA Tesla $826.55 / -17.94 (-2.12%) 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th 01/11/21 Notable open interest changes for January 11th 01/08/21 Notable open interest changes for January 8th

Recommendations	Turning Point Therapeutics price target raised to $190 from $130 at H.C. Wainwright » 06:25 01/19/21 01/19 06:25 01/19/21 06:25 TPTX Turning Point Therapeutics $131.57 / -6.23 (-4.52%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate TPTX Turning Point Therapeutics $131.57 / -6.23 (-4.52%) 01/11/21 Turning Point Therapeutics expects cash to fund operations into 2024 01/11/21 Turning Point Therapeutics announces 2021 milestone targets 01/11/21 Turning Point Therapeutics, Zai Lab expand collaboration to include TPX-0022 12/08/20 Turning Point granted breakthrough therapy designation for repotrectinib TPTX Turning Point Therapeutics $131.57 / -6.23 (-4.52%) 01/12/21 Oppenheimer Turning Point Therapeutics price target raised to $150 from $130 at Oppenheimer 01/12/21 JMP Securities Turning Point Therapeutics price target raised to $160 from $125 at JMP Securities 01/12/21 Oppenheimer Turning Point Therapeutics price target raised to $150 from $130 at Oppenheimer 12/14/20 SVB Leerink Turning Point Therapeutics price target raised to $127 from $116 at SVB Leerink TPTX Turning Point Therapeutics $131.57 / -6.23 (-4.52%) 08/10/20 Turning Point Therapeutics reports Q2 EPS (82c), consensus (89c) 27 Oct 19 May
Recommendations	IGM Biosciences price target raised to $114 from $88 at H.C. Wainwright » 06:24 01/19/21 01/19 06:24 01/19/21 06:24 IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Options IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) 01/11/21 IGM Biosciences enters exclusive licensing agreement with Medivir for birinapant 12/06/20 IGM Biosciences presents first clinical data from IGM-2323 in NHL 11/05/20 IGM Biosciences sees 2020 non-GAAP operating expenses $80M-$85M 11/04/20 IGM Biosciences to present data from IGM-2323 in NHL IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) 12/22/20 Fly Intel: Top five analyst downgrades 12/22/20 Wedbush IGM Biosciences downgraded to Neutral at Wedbush 12/22/20 Wedbush IGM Biosciences downgraded to Neutral from Outperform at Wedbush 12/06/20 Piper Sandler IGM Biosciences price target raised to $89 from $81 at Piper Sandler IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) 11/05/20 IGM Biosciences reports Q3 EPS (66c), consenus (69c) 08/06/20 IGM Biosciences reports Q2 EPS (62c), consensus (64c) 09 Dec IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) 10/21/20 IGM Biosciences called 'next big bigtech collapse' by short-seller IGMS IGM Biosciences $97.37 / +2.365 (+2.49%) 08/12/20 Ten new option listings on August 12th
Upgrade	Brixmor upgraded to Buy from Neutral at BofA » 06:24 01/19/21 01/19 06:24 01/19/21 06:24 BRX Brixmor $16.86 / -0.025 (-0.15%) BofA analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BRX Brixmor $16.86 / -0.025 (-0.15%) 11/18/20 Collection Sites enters agreement with Brixmor to launch testing sites BRX Brixmor $16.86 / -0.025 (-0.15%) 06:11 Today BofA Brixmor upgraded to Buy from Neutral at BofA 12/30/20 Truist Brixmor price target raised to $17 from $13 at Truist 12/10/20 Wells Fargo Brixmor downgraded to Equal Weight at Wells Fargo 12/10/20 Wells Fargo Brixmor downgraded to Equal Weight from Overweight at Wells Fargo BRX Brixmor $16.86 / -0.025 (-0.15%) 11/04/20 Brixmor reports Q3 FFO 36c, consensus 40c 08/03/20 Brixmor reports Q2 NAREIT FFO 32c, consensus 35c 02/12/21 Brixmor - BRX
Hot Stocks	SPI Energy subsidiary, Icona announce collaboration for all-electric vehicles » 06:24 01/19/21 01/19 06:24 01/19/21 06:24 SPI SPI Energy $34.00 / +12 (+1.00%) SPI Energy subsidiary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly Options SPI SPI Energy $34.00 / +12 (+1.00%) 01/12/21 SPI Energy provides FY20 business update 01/06/21 SPI Energy subsidiary acquires consumer contracts of Petersen-Dean 12/01/20 SPI Energy announces Phoenix Motorcars delivery of two Z500 utility trucks 11/13/20 SPI Energy acquires Phoenix Motorcars for $11.5M in stock, $1M in cash 01 Oct SPI SPI Energy $34.00 / +12 (+1.00%) 01/12/21 Fly Intel: Pre-market Movers 10/27/20 Fly Intel: Pre-market Movers SPI SPI Energy $34.00 / +12 (+1.00%) 12/28/20 SPI Energy call volume above normal and directionally bullish 12/15/20 Largest borrow rate increases among liquid names 11/10/20 Largest borrow rate increases among liquid names 11/09/20 Largest borrow rate increases among liquid names
Recommendations	SpringsWorks price target raised to $101 from $87 at H.C. Wainwright » 06:24 01/19/21 01/19 06:24 01/19/21 06:24 SWTX SpringsWorks Therapeutics $79.90 / +5.665 (+7.63%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate SWTX SpringsWorks Therapeutics $79.90 / +5.665 (+7.63%) 12/15/20 SpringsWorks Therapeutics promotes Badreddin Edris to COO 11/04/20 Allogene expects IND to be submitted by year-end on ALLO-715 w/ nirogacestat 10/26/20 Jazz Pharmaceuticals acquires SpringWorks Therapeutics' FAAH inhibitor program 10/05/20 SpringsWorks Therapeutics, Pfizer announce clinical trial collaboration SWTX SpringsWorks Therapeutics $79.90 / +5.665 (+7.63%) 12/28/20 H.C. Wainwright SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright 12/17/20 JPMorgan SpringsWorks Therapeutics price target raised to $85 from $57 at JPMorgan 12/17/20 Barclays SpringsWorks Therapeutics price target raised to $83 from $70 at Barclays 10/29/20 H.C. Wainwright SpringsWorks Therapeutics price target raised to $73 from $58 at H.C. Wainwright SWTX SpringsWorks Therapeutics $79.90 / +5.665 (+7.63%) 11/12/20 SpringsWorks Therapeutics reports Q3 EPS (51c), consensus (48c) 08/12/20 SpringsWorks Therapeutics reports Q2 EPS (47c), consensus (36c) 08 Oct

Earnings	Citrix sees FY21 adjusted EPS $6.20-$6.40, consensus $6.37 » 06:23 01/19/21 01/19 06:23 01/19/21 06:23 CTXS Citrix $132.09 / +0.07 (+0.05%) Sees FY21 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CTXS Citrix $132.09 / +0.07 (+0.05%) 06:08 Today Citrix raises quarterly dividend to 37c from 35c per share 06:05 Today Citrix to acquire Wrike for $2.25B in cash 06:01 Today Citrix to acquire Wrike for $2.25B in cash 10/20/20 Citrix and Upwork expand collaboration in flexible work models, talent access CTXS Citrix $132.09 / +0.07 (+0.05%) 10/23/20 Morgan Stanley Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley 10/23/20 RBC Capital Citrix price target lowered to $145 from $162 at RBC Capital 10/23/20 Citi Citrix price target raised to $205 from $195 at Citi 10/23/20 Morgan Stanley Citrix downgraded to Equal Weight from Overweight at Morgan Stanley CTXS Citrix $132.09 / +0.07 (+0.05%) 06:22 Today Citrix sees Q1 adjusted EPS $1.40-$1.45, consensus $1.47 06:07 Today Citrix reports Q4 adjusted EPS $1.46, consensus $1.33 10/22/20 Citrix sees FY21 EPS 6.20-$6.40, consensus $6.19 10/22/20 Citrix raises FY20 EPS $5.89-$5.99 from $5.65-$5.85, consensus 01/21/21 Citrix - CTXS CTXS Citrix $132.09 / +0.07 (+0.05%) 07/20/20 Early notable gainers among liquid option names on July 20th
Recommendations	Xoma price target raised to $56 from $30 at H.C. Wainwright » 06:23 01/19/21 01/19 06:23 01/19/21 06:23 XOMA Xoma $39.71 / + (+0.00%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings XOMA Xoma $39.71 / + (+0.00%) 11/16/20 Xoma earns $2M milestone from Takeda Pharmaceutical 11/11/20 Xoma earns $1M milestone payment from 2018 royalty purchase agreement 11/03/20 Xoma acquires royalty interest in four lysosomal storage disorder enzymes 10/28/20 Xoma earns $25M milestone payment as NIS793 enters Phase 2 study XOMA Xoma $39.71 / + (+0.00%) 03/10/20 H.C. Wainwright Novartis' recent R&D day driving interest in Xoma, says H.C. Wainwright XOMA Xoma $39.71 / + (+0.00%) 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 08/06/20 Xoma reports Q2 EPS (33c), consensus (38c)
Downgrade	Pandora A/S downgraded to Hold from Buy at HSBC » 06:23 01/19/21 01/19 06:23 01/19/21 06:23 PANDY Pandora A/S $0.00 / + (+0.00%) HSBC analyst Anne-Laure… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings PANDY Pandora A/S $0.00 / + (+0.00%) 12/08/20 Danske Bank Pandora A/S downgraded to Hold from Buy at Danske Bank 11/25/20 BofA Pandora A/S upgraded to Buy from Neutral at BofA 11/10/20 Morgan Stanley Pandora A/S price target raised to DKK 560 from DKK 360 at Morgan Stanley 11/04/20 Danske Bank Pandora A/S upgraded to Buy from Hold at Danske Bank PANDY Pandora A/S $0.00 / + (+0.00%) 08/17/20 Pandora A/S sees 2020 organic growth down 14% to down 20% 08/17/20 Pandora A/S reports Q2 organic growth down 38% vs. down 7% last year
Earnings	Citrix sees Q1 adjusted EPS $1.40-$1.45, consensus $1.47 » 06:22 01/19/21 01/19 06:22 01/19/21 06:22 CTXS Citrix $132.09 / +0.07 (+0.05%) Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CTXS Citrix $132.09 / +0.07 (+0.05%) 06:08 Today Citrix raises quarterly dividend to 37c from 35c per share 06:05 Today Citrix to acquire Wrike for $2.25B in cash 06:01 Today Citrix to acquire Wrike for $2.25B in cash 10/20/20 Citrix and Upwork expand collaboration in flexible work models, talent access CTXS Citrix $132.09 / +0.07 (+0.05%) 10/23/20 Morgan Stanley Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley 10/23/20 RBC Capital Citrix price target lowered to $145 from $162 at RBC Capital 10/23/20 Citi Citrix price target raised to $205 from $195 at Citi 10/23/20 Morgan Stanley Citrix downgraded to Equal Weight from Overweight at Morgan Stanley CTXS Citrix $132.09 / +0.07 (+0.05%) 06:07 Today Citrix reports Q4 adjusted EPS $1.46, consensus $1.33 10/22/20 Citrix sees FY21 EPS 6.20-$6.40, consensus $6.19 10/22/20 Citrix raises FY20 EPS $5.89-$5.99 from $5.65-$5.85, consensus 10/22/20 Citrix sees Q4 EPS $1.25-$1.35, consensus $1.31 01/21/21 Citrix - CTXS CTXS Citrix $132.09 / +0.07 (+0.05%) 07/20/20 Early notable gainers among liquid option names on July 20th
Recommendations	Biohaven price target lowered to $111 from $121 at H.C. Wainwright » 06:22 01/19/21 01/19 06:22 01/19/21 06:22 BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 01/18/21 Biohaven's troriluzole did not differentiate from placebo in Alzheimer's trial 01/07/21 Biohaven Pharmaceutical acquires Kleo Pharmaceuticals, forms Biohaven Labs 01/04/21 Biohaven Pharmaceutical starts Phase 3 Trial of troriluzole in OCD 12/16/20 Biohaven's rimegepant shows efficacy and safety for migraine in Phase 3 trial BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 04:54 Today Piper Sandler Biohaven should pull back to mid-$70's on Alzheimer's miss, says Piper Sandler 12/29/20 Cantor Fitzgerald Biohaven price target raised to $115 from $109 at Cantor Fitzgerald 12/23/20 Piper Sandler Piper 'comfortable' owning Biohaven shares into Alzheimer's readout 12/15/20 H.C. Wainwright Biohaven Pharmaceutical initiated with a Buy at H.C. Wainwright BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 11/09/20 Biohaven Pharmaceutical reports Q3 adj. EPS ($2.67), consensus ($2.89) 08/10/20 Biohaven Pharmaceutical reports Q2 non-GAAP EPS ($2.55), consensus ($2.61) 29 Jan

Events

Earnings calls, analyst events, roadshows and more

CMA
Today at 08:00

Comerica - CMA Conference Calls
PETS
Today at 08:00

PetMed Express - PETS Conference Calls
BAC
Today at 08:30

Bank of America - BAC Conference Calls
LOGI
Today at 08:30

Logitech - LOGI Conference Calls
HAL
Today at 09:00

Halliburton - HAL Conference Calls
EPAC
Today at 09:00

Enerpac Tool Group Corp Firm Sponsored Meetings

N86 W12500 Westbrook Crossing, Menomonee Falls, WI
OACB
Today at 09:00

OAKTREE ACQUISITION CORP. II Firm Sponsored Meetings

New York, NY
Today at 09:00

Healthcare Industry Meetings
GS
Today at 09:30

Goldman Sachs - GS Conference Calls
Today at 10:00

Board of Directors Meeting Government Event

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $16.00-18.00 15.647M Shares
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares
Fri	No deals

View All Syndicate Announcements »

INSU Acquisition Corporation II (Units) trading halted, news dissemination

TODAY'S FREE FLY STORIES

Get Full Fly Access